fashion -WSS

fashion

author：knowledge 2025-09-30 15:16:36 - browse：566

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： The Readout: Lenmeldy, GLP

Wikipedia

WSS

Scientists boost immune system in aging mice by making it youthful

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Opioid cravings were reduced by anti

Study says nonprofit hospitals fall short in charity care spending

Medicare Advantage enrollment hits roughly 33.4 million

Primary care physicians play key roles in Alzheimer's management

hotspot

fashion

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Congress may force more Covid

Apple is now the first public company to be valued at $3 trillion

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Moonlake's readout produced a cash windfall. Risks remain

Obamacare plans could cover weight loss drugs

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: mifepristone case, GLP

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

focus

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Oprah kicked off a national conversation on obesity. Let's have it

Weight loss drugs aren’t covered by Obamacare. That may change

Reporting on presidential health from Reagan to Trump and Biden

Roche subsidiary Foundation Medicine opens new headquarters

focus

focus

Wikipedia

leisure time